Cognetivity Neurosciences Ltd. Stock

Stocks

CGNSF

CA19243C1005

Advanced Medical Equipment & Technology

OTC Markets Traded
Market Closed - OTC Markets 20:19:29 25/06/2026 +04 5-day change 1st Jan Change
0.000001 USD -99.00% Intraday chart for Cognetivity Neurosciences Ltd. -.--% -

Valuation: Cognetivity Neurosciences Ltd.

Market Cap 1.2M 854K 743K 691K 635K 81.56M 1.22M 8.15M 3.2M 40.6M 3.21M 3.14M 136M P/E 2022
-2.9x
P/E 2023 -2.8x
Enterprise Value 245K 175K 152K 141K 130K 16.68M 249K 1.67M 654K 8.31M 656K 642K 27.85M EV / Sales 2022
-
EV / Sales 2023 437,922,999x
Free-Float
85.56%
Yield 2022 *
-
Yield 2023 -
Current year 0
Extreme 0
0
1 year 0
Extreme 0
0
3 years 0
Extreme 0
0.15
5 years 0
Extreme 0
0.71
10 years 0
Extreme 0
1.12
Manager TitleAgeSince
Chief Executive Officer 45 01/04/2013
Compliance Officer 67 21/12/2017
Director TitleAgeSince
Director/Board Member 45 01/01/2017
Director/Board Member 67 21/12/2017
Date Insider Type Main position Quantity % Market Cap.
15/04/24 Option

Founder

600,000 0.6697%
15/04/24 Option

Founder

600,000 0.6697%
23/06/23 Sell

Founder

1,108,160 1.3030%
Change 5-day change 1-year change 3-year change Capi.($)
-99.00%-.--% - - 93
+1.10%+9.42%-27.57%+0.51% 33.1B
+0.94%+1.50%-48.34%+135.02% 11.9B
-4.23%+0.53%-23.66%+61.26% 5.4B
-2.32%+4.60% - - 2.18B
-0.21%+4.48% - - 1.79B
-4.69%-13.73%+18.85%-42.67% 1.61B
+3.26%+2.03%-32.07% - 1.05B
-1.59%-0.91%+32.72%+99.08% 857M
+6.25%+12.97%-40.00%-51.10% 819M
Average -10.05%+1.58%-17.15%+33.68% 5.87B
Weighted average by Cap. +0.32%+5.73%-29.66%+35.92%

Financials

2022 2023
Net sales - 0.05 0.03 0.03 0.03 0.02 3.09 0.05 0.31 0.12 1.54 0.12 0.12 5.15
Net income -13.13M -9.36M -8.13M -7.57M -6.95M -893M -13.33M -89.25M -35.03M -445M -35.14M -34.37M -1.49B -7.43M -5.3M -4.61M -4.29M -3.94M -506M -7.55M -50.54M -19.84M -252M -19.9M -19.46M -844M
Net Debt -82.43K -58.76K -51.08K -47.54K -43.65K -5.61M -83.71K -560K -220K -2.79M -221K -216K -9.36M -953K -680K -591K -550K -505K -64.88M -968K -6.48M -2.54M -32.3M -2.55M -2.5M -108M
Logo Cognetivity Neurosciences Ltd.
Cognetivity Neurosciences Ltd. is a Canada-based technology company. The Company has developed a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical and commercial environments and other neurological conditions. The Company’s CognICA uses artificial intelligence and machine learning technology to test the performance of large areas of the brain to help detect early signs of cognitive dysfunction. It is also focused on developing the ICA for home use, for the remote monitoring of patient’s progress under treatment regimens and for general home healthcare check-ups. CognICA is available for clinical use in the United States, United Kingdom, Europe, Canada and the Middle East. Its subsidiaries include Cognetivity Ltd. and Cognetivity FZ-LLC.
Employees
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CGNSF Stock